 MELBOURNE, Australia and SAN FRANCISCO , July 1, 2021 PRNewswire -- Alterity Therapeutics ASX: ATH, NASDAQ: ATHE Alterity or the Company has today announced the granting of a new composition of matter patent by the United States Patent and Trademark Office USPTO. The patent secures a broad monopoly over a new class of iron chaperones, a technology capable of redistributing excess iron in the central nervous system. 